期刊文献+

冠状动脉旁路移植术112例围手术期处理 被引量:2

Peri-operative managements of 112 cases undergoing coronary artery bypass grafting
下载PDF
导出
摘要 目的探讨冠状动脉旁路移植术(CABG)的围手术期处理经验。方法2001-10~2008-08共施行CABG112例,其中行体外循环CABG106例,行非体外循环冠状动脉旁路移植术(OPCAB)6例;每例移植血管1~4支,平均(2.9±0.8)支。同期行心瓣膜手术6例,室壁瘤切除术3例。结果围术期病死3例(2.7%,3/112),死于低心排血量综合征2例,严重室性心律失常1例。术后发生心房纤颤25例。术后呼吸机辅助时间(12.8±9.9)h,住ICU时间(4.2±2.0)d,术后住院时间(13.2±5.6)d。随访85例(75.9%),随访时间1个月至8年,其中82例(96.5%)无心绞痛复发,心功能(NYHA)恢复至Ⅰ级47例,Ⅱ级30例,Ⅲ级8例。结论加强CABG围手术期处理,可降低手术病死率和并发症发生率,提高手术疗效。 Objective To investigate the peri-operative managements of coronary artery bypass grafting (CABG). Method From October 2001 to August 2008, 112 patients with coronary artery disease underwent CABG in authors' hospital. Among them 106 patients underwent conventional (on-pump) CABG and 6 patients underwent off-pump CABG (OPCAB). The number of bypass grafts for each patient was 1 to 5 (2.9±0.8). Cardiac valvular operations were performed in 6 patients. Left ventricular aneurysm plasty operation were performed in 3 patients. Result Three deaths occurred peri-operatively (2.7%). Two patients died of low cardiac output and one patient died of ventricular fibrillation after operation. The atrial fibrillation occurred in 25 patients postoperatively. The ventilation time was 12.8±9.9 hours. The intensive care unit stay was 4.2±2.0 days and postoperative in-hospital stay was 13.2±5.6 days. 85 patients (75.9%) were follow up, follow-up time was 1 month to 8 years. There were no angina in 82 payients (96.5%). There were 47 patients in New York Heart Association (NYHA) class I, 30 patients in NYHA class Ⅱ, 8 patients in NYHA class Ⅲ. Conclusion Intensive perioperative management can reduce the mortality and morbidity of CABG and improve the operative prognosis.
机构地区 [
出处 《实用医药杂志》 2009年第2期7-9,共3页 Practical Journal of Medicine & Pharmacy
关键词 冠状动脉粥样硬化性心脏病 冠状动脉旁路移植术 围术期处理 Coronary atherosclerotic heart disease Coronary artery bypass grafting Peri-operative management
  • 相关文献

参考文献10

  • 1吴清玉,孟强,胡盛寿,许建屏.瓣膜替换或成形术同期行冠状动脉旁路移植术的临床分析[J].中华医学杂志,2000,80(1):31-33. 被引量:17
  • 2段亮,肖明第,袁忠祥,杨迪成,胡振雷,王利民.同期行冠状动脉旁路移植及心瓣膜置换术80例[J].中国胸心血管外科临床杂志,2007,14(3):169-172. 被引量:16
  • 3He GW, Hughes CF, McCaughan B, et al. Mitral valve replacement combined with coronary operation: determinants of early and tate results. Ann Thorac Surg, 1991,51(6):916.
  • 4Ruvolo G, Speziale G, Bianchini R, et al. Combined coronary bypass grafting and mitral valve surgery: Early and late results. Thorac Cardiovasc Surg, 1995,43(2):90.
  • 5Grossi EA, Goldberg JD, Lapietra A, et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg, 2001,122(6):1107.
  • 6Mantovani V, Mariscalco G, Leva C, et al. Long-term resUhs of the surgical treatment of chronic ischemic mitral regurgitation: comparison of repair and prosthetic replacement. J Heart Valve Dis, 2004,13(3):421.
  • 7王玺胜,梅运清,李爱萍,胡大一.胺碘酮对冠状动脉旁路移植术后心房纤颤的预防作用[J].中华胸心血管外科杂志,2006,22(3):208-208. 被引量:2
  • 8Yilmqz AT, Demakili U, Arslan M, et al. Long-term prevention of atrial fibrillation after coronary artery bypass surgery: comparison of quinidine, verapamil, and amiodarone in maintaining sinus rhythm. J Card Surg, 1996,11:61.
  • 9Yagdi T, Nabantgil S, Ayik F, et al. Amiodaron reduces the incidence of atrial fibrillation after coronary bypass grofting. J Thorac Cardiovasc Surg, 2003,125:1420.
  • 10赵康丽,蒋雄京,聂叶玲,张雯,刘迎龙.冠状动脉旁路移植围手术期抗凝研究[J].中华胸心血管外科杂志,2005,21(1):33-34. 被引量:4

二级参考文献29

  • 1陈鑫,徐明,蒋英硕.同期心脏瓣膜手术与冠状动脉旁路移植术81例[J].中国胸心血管外科临床杂志,2006,13(3):158-161. 被引量:30
  • 2Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation(GABI). N Engl J Med, 1994,331:1037-1043.
  • 3Greaves S, Rutherford J, Aranki S, et al. Current incidence and determinants of perioperative myocardial infarction in corronary artery surgery. Am Heart J, 1996,132:572-578.
  • 4Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med, 1990,323:1781-1788.
  • 5Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med, 2002,347:1309-1317.
  • 6Stein PD, Dalem JE, Goldman S, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest, 1998,114:S658-665.
  • 7Cartier R, Robitaille D. Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg, 2001,121:920-922.
  • 8Shin H, Hashizume K, lino Y, et al. Effects of atrial fibrillation on coronary artery bypass graft flow. Eur J Cardiothorac Surg,2003,23:175 - 178.
  • 9Yilmqz AT, Demakili U, Arslan M, et al. Leng-term prevention of atrial fibrilltion after coronary artery bypass surgery: comparison of quinidine,verapamil, and amiodarene in maintaining sinus rhythm. J Card Surg, 1996,11:61 -64.
  • 10Yagdi T, Nabantgil S, Ayik F, et al. Amiodaron reduces the incidence of atrial fibrillation after coronary bypass grofting. J Thorac Cardiovasc Surg,2003,125:1420 - 1425.

共引文献35

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部